Physician

Afsaneh Amouzegar, MD

According to 2025 Medicare claims, Afsaneh Amouzegar, MD (NPI: 1609432038) practices hematology/oncology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Mateo, CA. This provider's primary affiliated billing organization is UNIVERSITY OF CALIFORNIA SAN FRANCISCO (NPI: 1164512851; TIN: 943281657) and primary practice location at 94143-2351.

Amouzegar's data goes back to 2015 and runs through 2024. Part D data shows 23 prescription claims totaling $347 in drug costs. Open Payments data shows 5 records totaling $396. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $2,171 to $347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$43K2019 Drug cost: $2,171 (USD; Tot_Drug_Cst)2020 Drug cost: $2,531 (USD; Tot_Drug_Cst)2021 Drug cost: $3,279 (USD; Tot_Drug_Cst)2022 Drug cost: $1,655 (USD; Tot_Drug_Cst)2023 Drug cost: $42,554 (USD; Tot_Drug_Cst)2024 Drug cost: $347 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R16$2,171
20202551$2,531
20211727$3,279
20221336$1,655
2023N/R13$42,554
2024N/R23$347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$396Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Afsaneh Amouzegar, MD?

Tedicare shows public-source Medicare data for Afsaneh Amouzegar, MD (NPI 1609432038), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afsaneh Amouzegar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Afsaneh Amouzegar, MD?

Afsaneh Amouzegar, MD is linked to UNIVERSITY OF CALIFORNIA SAN FRANCISCO (billing NPI 1164512851) in the available physician profile data.

Does Afsaneh Amouzegar, MD have Open Payments data?

Afsaneh Amouzegar, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.